Paal, K; Stranz, B; Hassler, E; Magyar, M; Brunner, TB; Langsenlehner, T; Partl, R
Prognostic Significance of Platelet-Leukocyte Ratio in Patients undergoing neoadjuvant radiochemotherapy for Rectal Cancer
STRAHLENTHER ONKOL. Abstracts. 2023; 199(S1):S74-S74.-29th Annual Congress of the DEGRO; JUN 22-24, 2023; Kassel, GERMANY.
[Poster]
Web of Science
Paal, K; Stranz, B; Thurner, E; Langsenlehner, T;
Association between age-related parameters and acute toxicity in prostate cancer radiotherapy
RADIOTHER ONCOL. Abstracts. 2023; 182: S1242-S1242.-Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO); MAY 12-16, 2023; Vienna, AUSTRIA.
[Poster]
Web of Science
Paal, K; Stranz, B; Thurner, EM; Brunner, TB; Langsenlehner, T;
Association between age-associated Biomarkers and radiogenic Acute Toxicity in Prostate Cancer Patients
STRAHLENTHER ONKOL. Abstracts. 2023; 199(S1):S12-S12.-29th Annual Congress of the DEGRO; JUN 22-24, 2023; Kassel, GERMANY.
[Oral Communication]
Web of Science
Paal, K; Stranz, B; Thurner, EM; Partl, R; Langsenlehner, U; Langsenlehner, T
To study the Effects of Radiation Therapy on the Health Status of geriatric Prostate Cancer Patients by using geriatric Assessments
STRAHLENTHER ONKOL. 2022; 198(SUPPL 1):S119-S120.
[Oral Communication]
Web of Science
Lukasiak, K; Stranz, B; Thurner, E; Stranzl-Lawatsch, H; Schippinger, W; Langsenlehner, U; Langsenlehner, T
Evaluation of the biological age in PCa patients treated with RT using a geriatric assessment
RADIOTHER ONCOL. 2021; 161: S1189-S1189.
[Poster]
Web of Science
Lukasiak, K; Stranz, B; Thurner, EM; Stranzl-Lawatsch, H; Partl, R; Langsenlehner, U; Langsenlehner, T
Application of geriatric Assessment in Prostate Cancer Patients before planned definitive Radiation Therapy
STRAHLENTHER ONKOL. 2021; 197(SUPPL 1):S26-S27.
[Oral Communication]
Web of Science
Petru, E; Schwarz, S; Haas, J; Stranz, B; Klocker, J; Graf, S; Winter, R; Lang, U
Niedrig-dosiertes Lenograstim (GranozyteR) als Prophylaxe nach hochgradiger Neutropenie beim letzten adjuvanten Chemotherapiezyklus mit (F)EC beim Mammakarzinom
Supplement 1/66. Jg; -56. Kongress der Dt. Ges. für Gynäkologie und Geburtshilfe (DGGG), ICC; September 2006; Berlin.
[Poster]